Myofibroblast specific targeting approaches to improve fibrosis treatment
- 9 November 2022
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (98) , 13556-13571
Abstract
Fibrosis has been shown to develop in individuals with underlying health conditions, especially chronic inflammatory diseases.Keywords
Funding Information
- NIH Office of the Director (R03OD032624)
- Cancer Prevention and Research Institute of Texas (PR210153)
This publication has 182 references indexed in Scilit:
- Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosisNature Communications, 2012
- Cadherin-11 regulates fibroblast inflammationProceedings of the National Academy of Sciences, 2011
- The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblastsArthritis & Rheumatism, 2011
- Regulation of TGF-β signalling by protein phosphatasesBiochemical Journal, 2010
- Role of SARA (SMAD Anchor for Receptor Activation) in Maintenance of Epithelial Cell PhenotypeJournal of Biological Chemistry, 2009
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- TANGO1 Facilitates Cargo Loading at Endoplasmic Reticulum Exit SitesCell, 2009
- HPMA Polymer-Based Site-Specific Delivery of Oligonucleotides to Hepatic Stellate CellsBioconjugate Chemistry, 2009
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcAThe EMBO Journal, 2007